Bourgain R H, Maes L, Andries R, Braquet P
Prostaglandins. 1986 Jul;32(1):142-4. doi: 10.1016/0090-6980(86)90157-7.
The anti-thrombotic effects of specific paf-acether antagonist BN 52021 were compared to the effects of Ginkgo Biloba extracts A, B, (A + B), and C. Local superfusion of BN 52021 over an experimentally injured arterial segment embolizes an existent paf-acether induced platelet thrombus. When applied before paf-acether, BN 52021 prevents local thromboformation in this model. Applied intravenously, BN 52021 reduces local thromboformation in a significant way. As compared to this BN 52021 standard, only Ginkgo Biloba B and the (A + B)-mixture present major thromboreductive activity.
将特定的血小板激活因子拮抗剂BN 52021的抗血栓形成作用与银杏叶提取物A、B、(A + B)和C的作用进行了比较。在实验性损伤的动脉段局部灌注BN 52021可使现有的由血小板激活因子诱导的血小板血栓栓塞。在血小板激活因子之前应用时,BN 52021可防止该模型中局部血栓形成。静脉内应用时,BN 52021可显著减少局部血栓形成。与该BN 52021标准相比,只有银杏叶提取物B和(A + B)混合物具有主要的抗血栓形成活性。